UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.35% |
| 2 | Technology | 17.79% |
| 3 | Financials | 9.18% |
| 4 | Industrials | 6.66% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TPHE
7301
DELISTED
Timothy Plan High Dividend Stock Enhanced ETF
TPHE
| $72.2K | ﹤0.01% |
2,763
-3,110
| -53% | -$80K |
2023 Q4
7 quarters
|
|
7302
KORU Medical Systems
KRMD
$139M
| $72.1K | ﹤0.01% |
18,834
+1,565
| +9% | +$5.99K |
2023 Q1
10 quarters
|
|
|
RSF
7303
RiverNorth Capital and Income Fund
RSF
$49.7M
| $72.1K | ﹤0.01% |
4,900
+2,500
| +104% | +$36.7K |
2021 Q3
16 quarters
|
|
7304
AN2 Therapeutics
ANTX
$212M
| $72K | ﹤0.01% |
56,694
-5,306
| -9% | -$6.07K |
2024 Q4
3 quarters
|
|
7305
PUT
iShares Future Exponential Technologies ETF
XT
$4B
| $71.9K | ﹤0.01% |
+1,000
| New | +$67.7K |
2025 Q3
0 quarters
|
|
|
GQGU
7306
GQG US Equity ETF
GQGU
$668M
| $71.6K | ﹤0.01% |
+2,835
| New | +$71K |
2025 Q3
0 quarters
|
|
|
PFO
7307
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$113M
| $71.4K | ﹤0.01% |
7,326
+205
| +3% | +$1.92K |
2014 Q4
43 quarters
|
|
7308
ZW Data Action Technologies
CNET
$6.82M
| $71.3K | ﹤0.01% |
30,460
+30,458
| +1,522,900% | +$49.4K |
2023 Q4
7 quarters
|
|
7309
T. Rowe Price Floating Rate ETF
TFLR
$836M
| $71.1K | ﹤0.01% |
+1,382
| New | +$71.3K |
2025 Q3
0 quarters
|
|
|
DAO
7310
Youdao
DAO
$1.83B
| $71K | ﹤0.01% |
7,143
-3,803
| -35% | -$34K |
2020 Q2
21 quarters
|
|
7311
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$20.3M
| $71K | ﹤0.01% |
1,094
+360
| +49% | +$27.9K |
2025 Q2
1 quarter
|
|
|
GENZ
7312
VanEck Digital Native Economy ETF
GENZ
$16.3M
| $70.6K | ﹤0.01% |
1,575
-1,347
| -46% | -$61K |
2014 Q4
43 quarters
|
|
7313
Sound Equity Dividend Income ETF
DIVY
$27.8M
| $70.5K | ﹤0.01% |
2,695
-636
| -19% | -$16.5K |
2024 Q2
5 quarters
|
|
7314
ALPS Active REIT ETF
REIT
$53.1M
| $70.3K | ﹤0.01% |
+2,624
| New | +$69.5K |
2025 Q3
0 quarters
|
|
7315
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$106M
| $70.3K | ﹤0.01% |
2,228
+34
| +2% | +$1.07K |
2021 Q4
15 quarters
|
|
7316
Biote Corp
BTMD
$33.3M
| $70K | ﹤0.01% |
23,343
+10,298
| +79% | +$36.8K |
2022 Q3
12 quarters
|
|
|
PN
7317
PN Smart Energy Ltd
PN
$40.6M
| $70K | ﹤0.01% |
5,284
+5,273
| +47,936% | +$193K |
2025 Q1
2 quarters
|
|
7318
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$28.5M
| $69.9K | ﹤0.01% |
4,868
-6,807
| -58% | -$182K |
2024 Q4
3 quarters
|
|
7319
Inuvo
INUV
$9.56M
| $69.8K | ﹤0.01% |
19,881
+15,806
| +388% | +$68K |
2024 Q2
5 quarters
|
|
7320
Highway Holdings
HIHO
$4.16M
| $69.4K | ﹤0.01% |
42,309
-13,765
| -25% | -$22.8K |
2024 Q4
3 quarters
|
|
7321
vTv Therapeutics
VTVT
$126M
| $69.3K | ﹤0.01% |
2,970
+123
| +4% | +$2.16K |
2024 Q1
6 quarters
|
|
|
IMVP
7322
Invesco India ETF
IMVP
$93.7M
| $69.3K | ﹤0.01% |
+2,764
| New | +$71.6K |
2025 Q3
0 quarters
|
|
7323
Koss Corp
KOSS
$37.3M
| $69.1K | ﹤0.01% |
13,607
+5,858
| +76% | +$33.2K |
2024 Q2
5 quarters
|
|
7324
Civeo
CVEO
$349M
| $68.9K | ﹤0.01% |
2,997
-7,705
| -72% | -$181K |
2023 Q1
10 quarters
|
|
7325
Fidelity Value Factor ETF
FVAL
$1.35B
| $68.9K | ﹤0.01% |
1,000
-179
| -15% | -$11.9K |
2025 Q2
1 quarter
|
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,171 new, 4,183 increased, 4,475 reduced and 1,086 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,171 new positions and closed 1,086 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.